XML 33 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Details)
 1 Months Ended 9 Months Ended
Aug. 11, 2020
Sep. 30, 2020
Stockholders' Equity (Textual)    
Agreements, description On August 11, 2020, the Company's Board of Directors approved the following equity grants: (i) 150,000 restricted stock units vesting quarterly over a period of two years to the Chairman of the Board of Directors of the Company and (ii) 100,000 restricted stock units vesting quarterly over a period of two years to each of the other three non-executive directors. On January 9, 2020, the Company entered into the Bonus Agreements and the Series B Purchase Agreement (as such terms are defined in Note 5 below), whereby, at the closing of both transactions, which occurred on February 19, 2020, (i) the Company sold 37% of future revenues (if any) from its LO2A Proceeds to Bonus, an Israeli company whose ordinary shares are traded on the Tel Aviv Stock Exchange ("TASE"), and invested cash amount of $7,400 in Bonus (of which $3,700 are held in trust) and (ii) in consideration, Bonus issued to the Company new ordinary shares of Bonus in a number equal to $16,400 divided by a purchase price per share of NIS 0.50 (approximately $0.12). The fair value of such Bonus ordinary shares received, based on a quote of the share price on January 9, 2020, the date of signing the Bonus Agreements, was $0.12 and, as of the date of the closing of the transactions, was $0.11.